OVIT (OncoVista Innovative Therapies) Receivables Turnover: 0.00 (As of Sep. 2015)


What is OncoVista Innovative Therapies Receivables Turnover?

OncoVista Innovative Therapies OVIT Receivables Turnover is 0.00 as of Sep. 2015.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. OncoVista Innovative Therapies's Revenue for the three months ended in Sep. 2015 was $0.00 Mil. OncoVista Innovative Therapies's average Accounts Receivable for the three months ended in Sep. 2015 was $0.00 Mil.

OncoVista Innovative Therapies  (OTCPK:OVIT) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

OncoVista Innovative Therapies Receivables Turnover Related Terms

OncoVista Innovative Therapies Receivables Turnover Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Receivables Turnover Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OVIT vs RSPI, HSTC, CAPS: Receivables Turnover Comparison

For the Biotechnology subindustry, OncoVista Innovative Therapies's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies Receivables Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's Receivables Turnover falls into.


OncoVista Innovative Therapies Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

OncoVista Innovative Therapies's Receivables Turnover for the fiscal year that ended in Dec. 2014 is calculated as

Receivables Turnover (A: Dec. 2014 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2014 ) / ((Accounts Receivable (A: Dec. 2013 ) + Accounts Receivable (A: Dec. 2014 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

OncoVista Innovative Therapies's Receivables Turnover for the quarter that ended in Sep. 2015 is calculated as

Receivables Turnover (Q: Sep. 2015 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Sep. 2015 ) / ((Accounts Receivable (Q: Jun. 2015 ) + Accounts Receivable (Q: Sep. 2015 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.00 mean?
OncoVista Innovative Therapies (OVIT) has a Receivables Turnover of 0.00 as of Sep. 2015. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Receivables Turnover too high?
OncoVista Innovative Therapies' current Receivables Turnover is 0.00.
How does OncoVista Innovative Therapies' Receivables Turnover compare to RSPI and HSTC?
OncoVista Innovative Therapies' Receivables Turnover of 0.00 can be compared against companies in the Biotechnology industry. The industry median Receivables Turnover is 5.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.28, based on 845 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on OncoVista Innovative Therapies and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OncoVista Innovative Therapies's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Receivables Turnover is 0.00 as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.